Shares of Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSE:AEZ) rose 5.2% during trading on Wednesday after Maxim Group raised their price target on the stock from $7.00 to $10.00. Maxim Group currently has a buy rating on …
AEterna Zentaris (NASDAQ:AEZS) is a biotech company that is undervalued and deserves a much high stock price based on analyst opinions and healthy pipeline prospects. AEZS, which now is at $1.15 per share, …
Seeking Alpha
The main US indexes rallied on Friday, with all three benchmarks closing at record highs for a second straight day amid widespread gains on the Standard & Poor’s 500 and all but four of the blue chips on the Dow Jones …
That is why, the aforementioned reverse stock split has so far succeeded in keeping AEZS's stock price afloat. The bad news, however, is that unless AEterna comes up with commercially viable updates sooner rather than …
Aeterna Zentaris Inc. (AEZS - Free Report) was a big mover last session, as the company saw its shares rise over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal …
ZACKS5mon
To read the entire report visit: www.microstockprofit.com/ads/AEZS See what investors are saying about AEZS at penny stock forum MicroStockProfit.com is a small-cap research and investment commentary provider. …
Stock market analysts and brokers have recently amended their target prices on shares of AEterna Zentaris Inc. (AEZS). The most recent analyst ratings issued by brokerages: 11/16/2016 – AEterna Zentaris Inc. had its …
The company has a market cap of $22.28 million and a P/E ratio of 0. Get the latest Aeterna Zentaris Inc (NASDAQ:AEZS) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for …
Alpha One analyzed the various web articles published on AEterna Zentaris Inc. (NASDAQ:AEZS), and thereafter it gave company a daily sentiment score of -0.024. The entity designs algorithm based assessment …